Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Annals of Surgery|December 22, 2020
Defining Common Features in High Impact and Highly Cited Journal Articles on Pancreatic Tumors: An Analysis of 1044 Studies Over the Past DecadeKavin Sugumar, Jonathan J Hue, Peter Ahorukomeye, et al.Surgery|December 30, 2020
The importance of multimodal therapy in the management of nonmetastatic adenosquamous carcinoma of the pancreas: Analysis of treatment sequence and strategyJonathan J Hue, Erryk Katayama, Kavin Sugumar, et al.The Journal of Surgical Research|April 18, 2022
Time to Neoadjuvant Chemotherapy Initiation Is not Associated With Survival in Pancreatic CancerJonathan J Hue, Kavin Sugumar, Mohamedraed Elshami, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 26, 2021
Mortality and Survival Among Octogenarians with Localized Pancreatic Head Cancer: a National Cancer Database AnalysisJonathan J Hue, Katherine Bingmer, Kavin Sugumar, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 12, 2021
Racial disparities in operative management of localized, non-functional pancreatic neuroendocrine tumors in surgically fit patientsKatherine E Bingmer, Jonathan J Hue, Kavin Sugumar, et al.Surgery|January 17, 2021
Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomyJonathan J Hue, Kavin Sugumar, Sarah C Markt, et al.Cancer Reports (Hoboken, N.J.)|July 10, 2021
The importance of time-to-adjuvant treatment on survival with pancreatic cancer: A systematic review and meta-analysisKavin Sugumar, Jonathan J Hue, Solanus De La Serna, et al.Annals of Surgical Oncology|August 25, 2023
Trends in and Prognostic Significance of Time to Treatment in Pancreatic Cancer: A Population-Based StudyKavin Sugumar, Jonathan J Hue, Shreya Gupta, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 10, 2022
Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysisKavin Sugumar, Alex Hurtado, Ilora Naik, et al.Journal of Pancreatic Cancer|May 3, 2021
Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic CancerJonathan J Hue, Katherine Bingmer, Kavin Sugumar, et al.Pageof 4